GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dr. Agarwal's Health Care AGARWALEYE.NS · INR

N/A · NSE · 🇮🇳 India

Compare

537.30

+4.06%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹20.80bn

FY2021FY2026

Net income

₹1.33bn

FY2021FY2026

Free cash flow

₹683.8m

FY2021FY2026

Shareholders' equity

₹20.25bn

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue₹20.80bn₹17.11bn₹13.32bn₹10.16bn₹6.95bn₹4.71bn
Research and development—————₹52.5m
Operating income₹2.93bn₹6.99bn₹5.15bn₹1.56bn₹885.8m₹2.64bn
Net income₹1.33bn₹834.6m₹1.02bn₹941.0m₹376.9m−₹554.8m
Diluted earnings per share4.182.623.313.371.18-1.74

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assets₹39.42bn₹36.72bn₹27.83bn₹18.25bn₹10.26bn₹7.87bn
Cash and short-term investments₹2.82bn₹5.22bn₹5.87bn₹1.61bn₹996.2m₹552.1m
Total liabilities₹18.22bn₹17.45bn₹13.89bn₹11.66bn₹7.92bn₹5.88bn
Debt₹10.66bn₹9.61bn₹9.68bn₹8.57bn₹6.19bn₹4.69bn
Shareholders' equity₹20.25bn₹18.67bn₹13.48bn₹6.30bn₹2.12bn₹1.84bn
Shares outstanding319m318m308m279m319m319m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations₹5.16bn₹3.31bn₹3.46bn₹2.33bn₹1.64bn₹991.6m
Capital spending−₹4.48bn−₹3.09bn−₹2.32bn−₹1.58bn−₹705.9m−₹1.27bn
Free cash flow₹683.8m₹227.9m₹1.14bn₹753.0m₹937.4m−₹273.9m
Dividends paid−₹10.9m−₹7.9m−₹7.7m−₹4.3m−₹70,000—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹6.14bn₹5.64bn₹5.30bn₹4.99bn₹4.87bn₹4.60bn₹4.31bn₹4.10bn
Operating income₹921.0m₹847.9m₹753.5m₹682.8m₹649.1m₹835.3m₹1.79bn₹1.55bn
Net income₹452.3m₹397.1m₹337.4m₹296.9m₹300.5m₹325.7m₹223.4m₹142.8m
Diluted earnings per share1.421.251.060.930.941.020.730.46
Cash from operations———₹2.62bn———₹1.01bn
Capital spending———−₹2.13bn———−₹634.0m
Free cash flow———₹495.0m———₹375.0m
Total assets—₹39.42bn—₹37.86bn—₹36.72bn—₹33.93bn
Cash and short-term investments₹2.84bn₹2.82bn₹3.97bn₹3.97bn₹5.13bn₹5.22bn₹4.91bn₹4.91bn
Debt—₹2.48bn—₹1.08bn—₹3.75bn—₹4.32bn
Shareholders' equity₹21.20bn₹20.25bn₹20.19bn₹19.31bn₹19.27bn₹18.67bn₹15.58bn₹15.04bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue27.0%34.6%—
Operating income23.5%2.1%—
Net income12.3%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin26.2%27.1%27.6%—
Net margin5.7%6.7%5.4%—

Valuation history

At each fiscal year end

FY2026FY2025
Price to earnings124.0193.9
Price to sales7.99.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.